Posts

Showing posts with the label Injection Pen Market

Injection Pen Market: Patent Expiry of Biologics to Drive the Demand for Biosimilars

  The growth of this market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support. The global  injection pen market  is projected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017 at a CAGR of 6.0% during the forecast period. Market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the benefits disposable pens offer, such as portability, ease of use, and low possibility of infection. Global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular...

Scenarios of impact of Coronavirus on Injection Pen Market

The ongoing COVID-19 pandemic—and the worldwide reaction to it—has compelled companies to radically rethink their strategies and the way they operate. We salute the industry experts helping companies survive and sustain in this pandemic. At MarketsandMarkets™, analysts are undertaking continuous efforts to provide analysis of the  COVID-19 impact on the Injection Pen Market . We are working diligently to help companies take rapid decisions by studying:  The impact of COVID-19 on the Injection Pen Market, including growth/decline in product type/use cases due to the cascaded impact of COVID-19 on the extended ecosystem of the market  The rapid shifts in the strategies of the Top 50 companies in the Injection Pen Market  The shifting short-term priorities of the top 50 companies’ clients and their client’s clients  You can request an in-depth analysis detailing the impact of COVID-19 on the Injection Pen Market:  https://www.marketsandmarkets.com/s...

Global Injection Pen Market Dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France)

Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption among patients. The  global  injection pen market  is expected to reach $41.38 Billion by 2022 from $30.97 Billion in 2017, at a  CAGR  of 6.0%. Segments The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable and reusable injection pens. The disposable injection pens segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the benefits disposable pens offer, such as portability, ease of use, and low possibility of infection. Based on therapy, the global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseas...

Emerging Trends in Injection Pen Market by Types, Revenue, Industry Growth and Forecast 2022

Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption amongst patients. The global  injection pen market  is expected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017, at a CAGR of 6.0%. Market Dynamics  + Drivers + Growing Prevalence of Chronic Diseases + Increasing Number of Regulatory Approvals + Favorable Reimbursement and Government Support Request for Free Sample Pages -  https://www.marketsandmarkets.com/requestsampleNew.asp?id=42342539 The global injection pen market is segmented into diabetes, growth hormone therapy, osteoporosis, fertility, and other therapies (such as multiple sclerosis, obesity, cardiovascular diseases, rheumatoid arthritis, and migraine). The diabetes segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the large diabet...

Injection Pen Market for Diabetes Therapy, By Region, 2015–2022 (USD Million)

What are the Global Growth Factors? The global  injection pen market  growth is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support. What the Experts Says about the Market Growth? The   injection pen market  was valued at USD 29.47 Billion in 2016 and is projected to reach USD 41.38 Billion by 2022, at a CAGR of 6.0% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Browse and in-depth TOC on “ Injection Pen Market ” 92 – Tables 28 - Figures 135 - Pages View more detailed TOC @  https://www.marketsandmarkets.com/Market-Reports/injection-pen-market-42342539.html The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable a...